A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
James McClellan, 53, is suing the firm claiming he was branded an 'old buffer' and forced out of his account manager job.
A family's desperate bid to stop a teacher joining Islamic State has been revealed in emotional recordings.
Wednesday unsavoury incident involving Jonny Evans and Papiss Cisse is the latest in a long line of gob-related football controversy